Literature DB >> 16438145

Survey on the management of dengue infection in Sri Lanka: opinions of physicians and pediatricians.

S A M Kularatne1.   

Abstract

The management of dengue infection is variable and clinicians often adopt their own methods based on clinical experience. Hence, there is a lack of uniformity in the practice and management of dengue fever (DF) and dengue hemorrhagic fever (DHF) in Sri Lanka. The objectives were to describe the opinions of clinicians regarding certain management issues of, and their clinical experiences in DF/DHF. A self-administered questionnaire survey of 50 consultant physicians and pediatricians that were currently practicing in Government Hospitals was conducted. Their cumulative experience was based on managing approximately 15,119 patients for a period of three years in 15 districts of the island. The WHO guidelines were used by only 16(45%) physicians and 6(40%) pediatricians in the management of DF/DHF Most of the clinicians did not agree on the value of steroids and antibiotics. However, the majority was in favor of platelet and plasma transfusions, although most had no fixed policy on fluid management. In the experience, clinicians observed the recurrence of dengue, post-viral fatigue syndrome, and many other complications. A conclusion was made that a national policy and guidelines should be created to suit the local context, based on the evidence and experiences of clinicians managing dengue infection.

Entities:  

Mesh:

Year:  2005        PMID: 16438145

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  17 in total

1.  Effect of high dose of steroid on plateletcount in acute stage of dengue Fever with thrombocytopenia.

Authors:  K C Shashidhara; K A Sudharshan Murthy; H Basavana Gowdappa; Abhijith Bhograj
Journal:  J Clin Diagn Res       Date:  2013-07-01

Review 2.  Unexplained post-acute infection syndromes.

Authors:  Jan Choutka; Viraj Jansari; Mady Hornig; Akiko Iwasaki
Journal:  Nat Med       Date:  2022-05-18       Impact factor: 87.241

3.  Case series of fatal Leptospira spp./dengue virus co-infections-Puerto Rico, 2010-2012.

Authors:  Nicole M Pérez Rodríguez; Renee Galloway; Dianna M Blau; Rita Traxler; Julu Bhatnagar; Sherif R Zaki; Aidsa Rivera; Jose V Torres; David Noyd; Xavier E Santiago-Albizu; Brenda Rivera García; Kay M Tomashek; William A Bower; Tyler M Sharp
Journal:  Am J Trop Med Hyg       Date:  2014-08-04       Impact factor: 2.345

4.  Corticosteroid therapy in dengue infection- opinions of junior doctors.

Authors:  Senaka Rajapakse; Champa Ranasinghe; Chathuraka Rodrigo
Journal:  J Glob Infect Dis       Date:  2010-05

5.  Occurrence and correlates of symptom persistence following acute dengue fever in Peru.

Authors:  Eric S Halsey; Maya Williams; V Alberto Laguna-Torres; Stalin Vilcarromero; Victor Ocaña; Tadeusz J Kochel; Morgan A Marks
Journal:  Am J Trop Med Hyg       Date:  2014-01-27       Impact factor: 2.345

6.  Treatment of dengue fever.

Authors:  Senaka Rajapakse; Chaturaka Rodrigo; Anoja Rajapakse
Journal:  Infect Drug Resist       Date:  2012-07-23       Impact factor: 4.003

Review 7.  Economic and disease burden of dengue in Southeast Asia.

Authors:  Donald S Shepard; Eduardo A Undurraga; Yara A Halasa
Journal:  PLoS Negl Trop Dis       Date:  2013-02-21

8.  Dengue shock.

Authors:  Senaka Rajapakse
Journal:  J Emerg Trauma Shock       Date:  2011-01

9.  Characteristics and management patterns of patients admitted with Fever and thrombocytopenia to an acute general medical unit in sri lanka.

Authors:  Shiyana Ibrahim; Charith Horadagoda; Chinthaka Maithripala; Niroshan Lokunarangoda; Gayan Ranasinghe; Thanushi Wickramarathne; Senaka Rajapakse
Journal:  J Glob Infect Dis       Date:  2011-04

Review 10.  Use of multiple data sources to estimate the economic cost of dengue illness in Malaysia.

Authors:  Donald S Shepard; Eduardo A Undurraga; Rosemary Susan Lees; Yara Halasa; Lucy Chai See Lum; Chiu Wan Ng
Journal:  Am J Trop Med Hyg       Date:  2012-10-01       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.